Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Single-arm, Multicenter, Open-label, Phase I/II Trial of Allo-QuadCAR01-T, an Allogeneic CAR-T-cell Therapy Targeting CD19 and CD20, for the Treatment of Relapsed or Refractory B-cell Malignancies
This study is testing Allo-QuadCAR01-T, a new off-the-shelf CAR-T therapy for people with hard-to-treat B-cell cancers. Unlike current CAR-T treatments that us…
Lymphoma Diffuse Large B-cellLeukemia and LymphomaLeukemia Relapse+1 more
AvenCell Therapeutics, Inc.NCT07284433
A Study of Longitudinal Neurocognitive and Neuroimaging Evaluations for Adult Patients With Lymphoma Receiving CD19 CAR T Cell Therapy
The purpose of this study is to learn about possible changes in cognitive (mental) abilities, such as memory skills and concentration, and in brain anatomy (st…
Lymphoma Receiving CAR-T Therapy
Memorial Sloan Kettering Cancer CenterNCT04107285